The Ubiquitin Proteasome System in Neuromuscular Disorders: Moving Beyond Movement
- PMID: 32899400
- PMCID: PMC7503226
- DOI: 10.3390/ijms21176429
The Ubiquitin Proteasome System in Neuromuscular Disorders: Moving Beyond Movement
Abstract
Neuromuscular disorders (NMDs) affect 1 in 3000 people worldwide. There are more than 150 different types of NMDs, where the common feature is the loss of muscle strength. These disorders are classified according to their neuroanatomical location, as motor neuron diseases, peripheral nerve diseases, neuromuscular junction diseases, and muscle diseases. Over the years, numerous studies have pointed to protein homeostasis as a crucial factor in the development of these fatal diseases. The ubiquitin-proteasome system (UPS) plays a fundamental role in maintaining protein homeostasis, being involved in protein degradation, among other cellular functions. Through a cascade of enzymatic reactions, proteins are ubiquitinated, tagged, and translocated to the proteasome to be degraded. Within the ubiquitin system, we can find three main groups of enzymes: E1 (ubiquitin-activating enzymes), E2 (ubiquitin-conjugating enzymes), and E3 (ubiquitin-protein ligases). Only the ubiquitinated proteins with specific chain linkages (such as K48) will be degraded by the UPS. In this review, we describe the relevance of this system in NMDs, summarizing the UPS proteins that have been involved in pathological conditions and neuromuscular disorders, such as Spinal Muscular Atrophy (SMA), Charcot-Marie-Tooth disease (CMT), or Duchenne Muscular Dystrophy (DMD), among others. A better knowledge of the processes involved in the maintenance of proteostasis may pave the way for future progress in neuromuscular disorder studies and treatments.
Keywords: UPS; neuromuscular disorder; neuromuscular junction; proteasome; synapse; ubiquitin.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
Ubiquitin-Proteasome Pathway and Muscle Atrophy.Adv Exp Med Biol. 2018;1088:235-248. doi: 10.1007/978-981-13-1435-3_10. Adv Exp Med Biol. 2018. PMID: 30390254 Review.
-
Deubiquitinases in muscle physiology and disorders.Biochem Soc Trans. 2024 Jun 26;52(3):1085-1098. doi: 10.1042/BST20230562. Biochem Soc Trans. 2024. PMID: 38716888 Free PMC article. Review.
-
The Effect of Dysfunctional Ubiquitin Enzymes in the Pathogenesis of Most Common Diseases.Int J Mol Sci. 2020 Sep 1;21(17):6335. doi: 10.3390/ijms21176335. Int J Mol Sci. 2020. PMID: 32882786 Free PMC article. Review.
-
Interplay between the Ubiquitin Proteasome System and Ubiquitin-Mediated Autophagy in Plants.Cells. 2020 Oct 1;9(10):2219. doi: 10.3390/cells9102219. Cells. 2020. PMID: 33019500 Free PMC article. Review.
-
Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.FEBS J. 2017 Oct;284(19):3171-3201. doi: 10.1111/febs.14193. Epub 2017 Aug 29. FEBS J. 2017. PMID: 28786561
Cited by
-
Bap1/SMN axis in Dpp4+ skeletal muscle mesenchymal cells regulates the neuromuscular system.JCI Insight. 2022 May 23;7(10):e158380. doi: 10.1172/jci.insight.158380. JCI Insight. 2022. PMID: 35603786 Free PMC article.
-
Ixazomib, an oral proteasome inhibitor, exhibits potential effect in dystrophin-deficient mdx mice.Int J Exp Pathol. 2021 Feb;102(1):11-21. doi: 10.1111/iep.12383. Epub 2020 Dec 9. Int J Exp Pathol. 2021. PMID: 33296126 Free PMC article.
-
Ubiquitylomics: An Emerging Approach for Profiling Protein Ubiquitylation in Skeletal Muscle.J Cachexia Sarcopenia Muscle. 2024 Dec;15(6):2281-2294. doi: 10.1002/jcsm.13601. Epub 2024 Sep 16. J Cachexia Sarcopenia Muscle. 2024. PMID: 39279720 Free PMC article. Review.
-
Prenatal Skeletal Muscle Transcriptome Analysis Reveals Novel MicroRNA-mRNA Networks Associated with Intrauterine Growth Restriction in Pigs.Cells. 2021 Apr 24;10(5):1007. doi: 10.3390/cells10051007. Cells. 2021. PMID: 33923344 Free PMC article.
-
Ubiquitin-specific peptidases in lymphoma: a path to novel therapeutics.Front Pharmacol. 2024 Nov 27;15:1356634. doi: 10.3389/fphar.2024.1356634. eCollection 2024. Front Pharmacol. 2024. PMID: 39664521 Free PMC article.
References
-
- Deng H.X., Chen W., Hong S.T., Boycott K.Y., Gorrie G.H., Siddique N., Faisal Fecto Y.Y., Hong Zhai Y.S., Makito Hirano H.J., Rampersaud E., et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477:211–215. doi: 10.1038/nature10353. - DOI - PMC - PubMed